Eli Lilly Just Got One Step Closer to Dethroning Ozempic. Time to Buy the Stock?
Eli Lilly just received FDA approval for its obesity medication Zepbound, the sister treatment to its blockbuster drug Mounjaro.
Full Article
Eli Lilly Just Got One Step Closer to Dethroning Ozempic. Time to Buy the Stock?
Motley Fool
0 shares
1 views
You might like
Related news coverage
The OECD’s Recipes For The Spanish Economy – Analysis
Eurasia Review
By William Chislett
The OECD’s latest economic survey of Spain coincides with the Socialist-led minority government..